Bicycle Therapeutics plc (BCYC) Stock Forecast
Data as of Aug 6, 2026Healthcare · Current price $3.96 (-0.38%)
Price Target Range
Consensus Price Target Over Time
Analyst Rating Distribution
Last 3 Months
6-Month Trend
Latest Analyst Forecasts
Price targets issued by Wall Street analysts. Upside calculated against today's price.
BCYC vs Sector & Market
| Metric | BCYC | Healthcare Avg | Large Cap Avg |
|---|---|---|---|
| Analyst Rating | 2.40 | 2.25 | 2.42 |
| Analyst Count | 5 | 8 | 18 |
| Target Upside | +176.8% | +16316.0% | +17.2% |
| P/E Ratio | -1.48 | 3.41 | 35.26 |
Revenue Estimates
| Period | Low | Avg | High | # |
|---|---|---|---|---|
| 2026-09-30 | $5M | $7M | $9M | 4 |
| 2026-12-31 | $4M | $7M | $8M | 5 |
| 2027-03-31 | $58M | $86M | $111M | 3 |
| 2027-06-30 | $65M | $97M | $125M | 3 |
| 2027-09-30 | $73M | $109M | $140M | 3 |
| 2027-12-31 | $82M | $123M | $158M | 3 |
EPS Estimates
| Period | Low | Avg | High | # |
|---|---|---|---|---|
| 2026-09-30 | $-0.66 | $-0.48 | $-0.27 | 3 |
| 2026-12-31 | $-0.60 | $-0.44 | $-0.25 | 4 |
| 2027-03-31 | $-0.83 | $-0.61 | $-0.34 | 2 |
| 2027-06-30 | $-0.83 | $-0.61 | $-0.34 | 2 |
| 2027-09-30 | $-0.85 | $-0.62 | $-0.35 | 2 |
| 2027-12-31 | $-0.88 | $-0.64 | $-0.36 | 2 |
Frequently Asked Questions
What is the analyst consensus for BCYC?
The consensus among 5 analysts covering Bicycle Therapeutics plc (BCYC) is Buy with an average price target of $10.67.
What is the highest price target for BCYC?
The highest analyst price target for BCYC is $12.00.
What is the lowest price target for BCYC?
The lowest analyst price target for BCYC is $8.00.
How many analysts cover BCYC?
5 analysts have issued ratings for Bicycle Therapeutics plc in the past 12 months.
Is BCYC a buy or sell right now?
Based on 5 analyst ratings, BCYC has a consensus rating of Buy (2.40/5) with a +176.8% upside to the consensus target of $10.67.
What are the earnings estimates for BCYC?
Analysts estimate BCYC will report EPS of $-0.48 for the period ending 2026-09-30, with revenue estimated at $7M.
Related Stock Forecasts
Data updated daily. Analyst price targets sourced from public filings and broker reports. Not investment advice.